Navigation Links
Non-Drug ADHD Treatments Don't Pan Out in Study
Date:1/30/2013

By Barbara Bronson Gray
HealthDay Reporter

WEDNESDAY, Jan. 30 (HealthDay News) -- Many parents pursue costly and time-consuming treatments to help their children with attention-deficit/hyperactivity disorder. Now, a new study finds little evidence that non-drug interventions reduce key symptoms of ADHD.

A multinational team of experts identified no positive effects from psychological treatments including mind exercises (cognitive training), neurofeedback and behavioral training (positive reinforcement). And the researchers discovered only small benefits associated with dietary treatments: supplementation with omega-3 and omega-6 free fatty acids, and elimination of artificial food coloring.

Still, parents shouldn't be discouraged, said study co-author Dr. Emily Simonoff.

"I think our findings allow a much more informed discussion than did previous work because we've been able to demonstrate that what we once thought worked is more limited and more questionable," said Simonoff, a professor of child and adolescent psychiatry at King's College London.

Simonoff thinks the study conclusions need to be interpreted in the context of a child's particular situation.

"I think people need to talk with their child's clinician," she said. "Evidence is never a substitute for having a discussion about your own child and what is right for your child and your family."

ADHD diagnoses are on the rise. Between 1997 and 2007, diagnoses among U.S. children and teens increased between 3 percent and 6 percent a year, according to the U.S. Centers for Disease Control and Prevention. According to the American Psychiatric Association, between 3 percent and 7 percent of U.S. children have the condition, which makes it hard to focus in school and to sustain friendships. Currently, a combination of medication and behavior therapy is the recommended treatment, according to the CDC.

The new review, an analysis of 54 studies by the European ADHD Guidelines Group, compared "blinded" and "unblinded" ratings for several dietary and psychological treatments. "Blinded" raters are unaware of the treatment used, while "unblinded" judges know of the therapy. It is thought that blinded ratings eliminate bias.

The study, published online Jan. 30 in the American Journal of Psychiatry, found that treatments were rated more effective in the unblinded tests, which appears to invalidate the conclusions.

Even after learning of the study findings, some people might say it can't hurt to try a particular therapy. But Simonoff warned of potential negative side effects.

"Adverse effects are often associated with pharmacological therapies, but other interventions can have them as well," she said. "For example, does a highly selective diet limit the way a child can play and socialize, making them feel different from their friends? And for parents, if a child doesn't improve under these therapies, does it affect how the parents feel about themselves?"

Dr. Andrew Adesman, chief of developmental and behavioral pediatrics at Steven and Alexandra Cohen Children's Medical Center of New York in New Hyde Park, agreed: "The danger in saying it won't hurt [to use non-drug therapies] is, where do you draw the line and what's the rationale?"

Attempting other therapies "instead of something that works," he said, results in lost time and money, false hopes, and missed opportunities.

Adesman said, however, that he was surprised that behavioral therapy was not found to be effective. "Unlike neurofeedback, elimination diets or attention training, the American Academy of Pediatrics does recommend behavioral therapy for ADHD in children," he said. "It involves psychologists working with parents to elicit better behavior in their kids, using positive and negative reinforcement, like time-outs."

Even if therapy doesn't improve the core symptoms of ADHD, such as attention span and impulsiveness, it may provide other benefits to the child and family, such as teaching effective communication strategies, Adesman said.

He also encourages parents to be open to the potential benefit drug therapy may provide.

"When I hear parents say they'll consider medicine only as a last resort, that's dangerous," he said. "Parents should confer with their child's pediatrician and discuss a range of treatment approaches and recognize that often the reason a medicine is suggested is not because of a physician's bias but rather because the data is generally stronger than for other treatments."

The European ADHD Guidelines Group received support for the study from Brain Products GMBH and drug makers Janssen-Cilag, Lilly, Medice, Shire and Vifor Pharma.

More information

Learn more about ADHD from the U.S. Centers for Disease Control and Prevention.

SOURCES: Emily Simonoff, M.D., professor of child and adolescent psychiatry, head of department, Institute of Psychiatry, King's College London; Andrew Adesman, M.D., chief of developmental and behavioral pediatrics, Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park; Jan. 30, 2013, American Journal of Psychiatry


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Feelings of immaturity accompany alcohol misuse into adulthood; discovery could improve treatments
2. Research May Point to New Obesity Treatments
3. Researchers make promising discovery in pursuit of effective lymphoma treatments
4. Study examines treatments for relieving breathing difficulties among patients with lung effusions
5. LA BioMeds Dr. Patricia Dickson researching treatments for neurodegenerative disorders
6. Pre-op Treatments Boost Survival for Esophageal Cancer Patients: Study
7. 1960s-era anti-cancer drug points to treatments for Lou Gehrigs disease
8. Rejuv Medical In Sartell, MN Now Offering Stem Cell Treatments
9. MDS researchers join forces to advance patient treatments and outcomes
10. New Treatments Emerging from Immune and Inflammatory Disease R&D Pipelines
11. Few Migraine Sufferers Referred for Behavioral Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Non-Drug ADHD Treatments Don't Pan Out in Study
(Date:4/24/2017)... , ... April 24, 2017 , ... ... rising prescription opioid overdose deaths now claim the lives of 62 Americans each ... case filings against drug manufacturers, distributors, pharmacies and prescribers by more than half.(2) ...
(Date:4/24/2017)... ... April 24, 2017 , ... Rod Burkett, CEO of ... News website. , Rod has been at the forefront of Gardant since it was ... CEO, Rod has overseen the opening of more than 40 new senior living communities. ...
(Date:4/24/2017)... ... April 24, 2017 , ... Come to PAINWeekEnd (PWE) Tampa on ... Blvd, for an educational and exciting 2-day program. , An attendee at a ... before they approach patients” about the course entitled Ain't Misbehavin': Decreasing and Managing Pain ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... that over the last decade, student well-being has seriously declined. "When disenfranchised youth ... formal education, join the Islamic State to turn the historic multi-ethnic and multi-religious ...
(Date:4/24/2017)... ... April 24, 2017 , ... “The Saint with Trin, and Omega ... Omega Station” is the creation of published author, Chris Jackson. Chris Jackson grew ... works in the Dallas Independent School District teaching English. He is heavily involved in ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage ... unmet medical needs, today announced that it will ... development program, based on its proprietary self-delivering RNAi ... (SID) 76 th Annual Meeting.  The SID ... relevant to skin health and disease through education, ...
(Date:4/20/2017)... , April 20, 2017  CVS Pharmacy, the ... unveiled a new store design to enhance the ... healthier food, health-focused products and expanded beauty selections ... help customers discover new offerings. Together with its ... evolution of the customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ... 99 percent (n=145/146) of chronic hepatitis C virus ... 5 or 6 and compensated cirrhosis (Child-Pugh A) ... (SVR 12 ) with its investigational, pan-genotypic regimen ... rates were seen following 12 weeks of G/P ...
Breaking Medicine Technology: